Free Trial

Passage Bio (PASG) Earnings Date, Estimates & Call Transcripts

Passage Bio logo
$0.41 -0.05 (-10.19%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$0.42 +0.00 (+0.92%)
As of 03/27/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Passage Bio Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 13Before Market OpensEstimated
Actual EPS
(Mar. 4)
-$0.20 Beat By $0.01
Consensus EPS
(Mar. 4)
-$0.21

Passage Bio released Q4 2024 earnings on March 4, 2025, reporting an EPS of -$0.20, which beat the consensus estimate of -$0.21 by $0.01. With a trailing EPS of -$1.07, Passage Bio's earnings are expected to grow next year, from ($1.03) to ($0.74) per share.

PASG Upcoming Earnings

Passage Bio's next earnings date is estimated for Tuesday, May 13, 2025, based off prior year's reporting schedules.

Get Passage Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Passage Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PASG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PASG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Passage Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.22-$0.22-$0.22
Q3 20251-$0.17-$0.17-$0.17
Q4 20251-$0.17-$0.17-$0.17
FY 20254($0.79)($0.79)($0.79)
Remove Ads

Passage Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
-------
3/4/2025Q4 2024-$0.21-$0.20+$0.01-$0.20--
8/8/2024--$0.31-$0.26+$0.05-$0.26--
5/14/2024Q1 2024-$0.37-$0.30+$0.07-$0.30--
3/4/2024Q4 2023-$0.41-$0.30+$0.11-$0.30--
11/13/2023Q3 2023-$0.46-$0.49 -$0.03-$0.49--
8/7/2023Q2 2023-$0.47-$0.44+$0.03-$0.44--
5/11/2023Q1 2023-$0.49-$0.63 -$0.14-$0.63--

Passage Bio Earnings - Frequently Asked Questions

Passage Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on PASG's earnings history.

In the previous quarter, Passage Bio (NASDAQ:PASG) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.01. Learn more on analysts' earnings estimate vs. PASG's actual earnings.

Passage Bio (NASDAQ:PASG) has a recorded net income of -$102.06 million. PASG has generated -$1.07 earnings per share over the last four quarters.

Passage Bio's earnings are expected to grow from ($1.03) per share to ($0.74) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:PASG) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners